relevant product failures since neither physicians nor buyers have all of the knowledge necessary to make sufficient judgments of merchandise quality and authorized tort therapies are sluggish, inefficient, and intensely highly-priced. The adjustments to your CGMP regulation will require manufacturers to extend [Site 52644] their high-quality devic